Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
09/2013
09/11/2013CN103298794A Pyridine compounds and aza analogues thereof as TYK2 inhibitors
09/11/2013CN103289087A Preparation method for benzoxazine-epoxy resin
09/11/2013CN103288815A Beta-lactamyl vasopression V1a antagonists
09/11/2013CN103288814A Preparation method of rivaroxaban intermediate
09/11/2013CN103288813A Preparation method of aprepitant
09/11/2013CN103288803A Benzimidazole amide compound as well as preparation method and application thereof
09/11/2013CN103288793A Phenethanolamine derivatives for treatment of respiratory diseases
09/11/2013CN103288738A Nitrogen-containing heterocyclic derivative having 11 beta-hydroxysteroid dehydrogenase type I inhibitory activity
09/11/2013CN103288721A (4-(4-[6-(trifluoromethyl-pyridin-3-ylamino)-n-containing-heteroaryl]-phenyl)-cyclohexyl)-acetic acid derivatives and pharmaceutical uses thereof
09/11/2013CN102206211B Method for preparing and synthesizing chiral oxazoline
09/11/2013CN102127064B Preparation method of azithromycin intermediate
09/11/2013CN102086211B Aromatic heterocyclic compounds serving as protein kinase inhibitor
09/11/2013CN101959882B 咪唑羰基化合物 Imidazole-carbonyl compound
09/11/2013CN101657441B Pyrazolone derivatives as PDE4 inhibitors
09/11/2013CN101501028B 2-(heterocyclylbenzyl)-pyridazinonderivate
09/11/2013CN101365676B Azetidines as mek inhibitors for the treatment of proliferative diseases
09/10/2013US8530670 Inhibitors
09/10/2013US8530505 Substituted oxazolidinones and their use in the field of blood coagulation
09/10/2013US8530470 Chromenone derivatives
09/10/2013US8530468 Bicyclylaryl-aryl-amine compounds and their use
09/10/2013US8530467 Benzoimidazole compounds and uses thereof
09/10/2013US8530462 Indole modulators of S1P receptors
09/10/2013CA2758894C Novel thyroid hormone .beta. receptor agonist
09/10/2013CA2727762C Process for synthesizing thioether precursors of herbicides by reaction of anilines with dialkyl disulfides in the presence of an alkyl nitrite
09/10/2013CA2691474C Cyanoisoquinoline
09/10/2013CA2669687C Phthalazine derivatives
09/10/2013CA2614544C Heterocycle-substituted benzimidazole derivative
09/10/2013CA2602199C Heteroaryl urea derivatives useful for inhibiting chk1
09/10/2013CA2570197C Nk1 antagonists
09/10/2013CA2561014C Thioamide derivatives as progesterone receptor modulators
09/10/2013CA2451566C Use of nk-1 receptor antagonists for the treatment of brain, spinal or nerve injury
09/06/2013WO2013130976A1 Serine/threonine kinase inhibitors
09/06/2013WO2013130892A1 Liver x receptor (lxr) modulators for the treatment of dermal diseases, disorders and conditions
09/06/2013WO2013130855A1 Indazole derivatives
09/06/2013WO2013128465A1 Cyclic amide derivatives as inhibitors of 11 - beta - hydroxysteroid dehydrogenase and uses thereof
09/06/2013WO2013128421A1 Spirohydantoin compounds and their use as selective androgen receptor modulators
09/06/2013WO2013127784A1 Microbiocidal pyrazole derivatives
09/06/2013WO2013127768A1 Pyridine carboxamide pesticides
09/06/2013WO2013127729A1 6 - alkynyl pyridines as smac mimetics
09/06/2013WO2013106646A3 Compounds and methods for the inhibition of vcb e3 ubiquitin ligase
09/06/2013WO2013106643A3 Compounds & methods for the enhanced degradation of targeted proteins & other polypeptides by an e3 ubiquitin ligase
09/05/2013US20130231477 Novel method of preparing benzoimidazole derivatives
09/05/2013US20130231373 Hydroxamate-based inhibitors of deacetylases
09/05/2013US20130231352 Heterocyclic compounds and their uses
09/05/2013US20130231344 Compounds that modulate intracellular calcium
09/05/2013US20130231342 Arylcyclopropylamine based demethylase inhibitors of lsd1 and their medical use
09/05/2013US20130231340 Pharmaceutical compounds
09/05/2013US20130231336 Substituted pyrimidinyl-amines as protein kinase inhibitors
09/05/2013US20130231326 Selective sphingosine 1 phosphate receptor modulators and methods of chiral synthesis
09/04/2013EP2634185A1 TYK2 kinase inhibitors
09/04/2013EP2632921A1 Polymorphs and salts of 6-(1h-indol-4-yl)-4-(5- { [4-(1-methylethyl)-1-pi perazinyl]methyl} -1,3-oxazol-2-yl)-1h-indazole as pi3k inhibitors for use in the treatment of e.g. respiratory disorders
09/04/2013EP2632920A1 Sulfonamides for the modulation of pkm2
09/04/2013EP2632918A1 Alpha-7 nicotinic receptor modulators for the treatment of pain, a psychotic disorder, cognitive impairment or alzheimer's disease
09/04/2013EP2632906A1 Oxazoline and isoxazoline derivatives as crac modulators
09/04/2013EP2632899A1 Substituted phenoxypyridines
09/04/2013EP2632465A1 Inhibitors of the renal outer medullary potassium channel
09/04/2013EP2632461A1 Isoindolinone pde10 inhibitors
09/04/2013EP2632268A2 Novel compounds that are erk inhibitors
09/04/2013EP2632255A1 Diazeniumdiolate heterocyclic derivatives
09/04/2013CN103282360A Cxcr4受体拮抗剂 Cxcr4 receptor antagonist
09/04/2013CN103282358A Cyp11b, cyp17, and/or cyp21 inhibitors
09/04/2013CN103282357A Pyrrolidine derivatives as NK3 antagonists
09/04/2013CN103282351A Substituted phenoxypyridines
09/04/2013CN103282345A Method for preparing substituted isoxazoline compounds and their precursors 4-hloro, 4-bromo- or 4-iodobenzaldehyde oximes
09/04/2013CN103275075A 佐米曲普坦及其制备方法 Zolmitriptan and its preparation method
09/04/2013CN103275067A Inhibitors of histone deacetylase
09/04/2013CN102503906B Formyl hydroxylamine type peptide deformylase inhibitor containing oxazole ring, as well as preparation method and use thereof
09/04/2013CN101374820B Piperazine compounds with a herbicidal action
09/03/2013US8524900 Fused heterocyclic derivatives and methods of use
09/03/2013US8524897 Crystalline oxazine derivative
09/03/2013US8524894 Inhibitor compounds of 11-beta-hydroxysteroid dehydrogenase type 1
09/03/2013US8524746 Dosage regimen for COMT inhibitors
09/03/2013US8524724 Alkynylpyrimidines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
09/03/2013US8524711 Amino-derivatives as novel inhibitors of histone deacetylase
09/03/2013US8524709 Kinase inhibitor compounds
09/03/2013US8524699 Substituted dihydropyrazolones and use thereof as HIF-prolyl-4-hydroxylase inhibitors
08/2013
08/29/2013WO2013126132A1 Cyclic diaminopyrimidine derivatives
08/29/2013WO2013124826A1 Oxazolidin- 2 -one compounds and uses thereof as pi3ks inhibitors
08/29/2013WO2013124823A1 An improved process for the preparation of aprepitant
08/29/2013WO2013124748A1 Novel polymorphs of azilsartan medoxomil potassium
08/29/2013WO2013124335A1 Antiviral compounds
08/29/2013WO2013124169A1 Use of 1h-indazole-3-carboxamide compounds as glycogen synthase kinase 3 beta inhibitors
08/29/2013WO2012130798A8 Herbicidally and fungicidally active 3-phenylisoxazoline-5-carboxamides and 3-phenylisoxazoline-5-thioamides
08/29/2013US20130225826 Method for preparing substituted isoxazoline compounds and their precursors 4-chloro, 4-bromo- or 4-iodobenzaldehyde oximes
08/29/2013US20130225644 Modified lysine-mimetic compounds
08/29/2013US20130225600 Oxazoline and isoxazoline derivatives as crac modulators
08/29/2013US20130225596 Novel heterocyclic derivative and pharmaceutical composition comprising the same (as amended)
08/29/2013US20130225586 Compounds, compositions, processes of making, and methods of use related to inhibiting macrophage migration inhibitory factor
08/29/2013US20130225583 Substituted amino-triazolyl pde10 inhibitors
08/29/2013US20130225582 Biaryl-spiroaminooxzaoline analogues as alpha 2c adrenergic receptor modulators
08/29/2013US20130225581 Nitrogen-containing aromatic heterocyclic derivative
08/29/2013US20130225578 7-cyclylquinazoline derivatives and methods of use thereof
08/29/2013US20130225574 Oxazolidin-2-one compounds and uses thereof
08/29/2013US20130225567 5-Alkynyl Pyridine
08/29/2013US20130225530 Wogonin for the prevention and therapy of cardiac hypertrophy
08/29/2013US20130225524 Chemical Compounds
08/29/2013US20130224195 Substituted benzazoles and methods of their use as inhibitors of raf kinase
08/29/2013US20130224186 Oxazole and thiazole compounds as ksp inhibitors
08/29/2013CA2857262A1 Antiviral compounds
08/28/2013EP2631229A1 P2x4 receptor antagonist
1 ... 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 ... 647